Design of phase II cancer trials using a continuous endpoint of change in tumor size: application to a study of sorafenib and erlotinib in non small-cell lung cancer (Q46982023)
Jump to navigation
Jump to search
scientific article published on 25 September 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Design of phase II cancer trials using a continuous endpoint of change in tumor size: application to a study of sorafenib and erlotinib in non small-cell lung cancer |
scientific article published on 25 September 2007 |
Statements
1 reference
Design of phase II cancer trials using a continuous endpoint of change in tumor size: application to a study of sorafenib and erlotinib in non small-cell lung cancer (English)
1 reference
Mark J Ratain
1 reference
Theodore G Karrison
1 reference
Michael L Maitland
1 reference
Walter M Stadler
1 reference
25 September 2007
1 reference
99
1 reference
19
1 reference
1455-1461
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference